Review
doi: 10.2174/187152708787122969.
Alzheimer's disease, ceramide, visfatin and NAD
Affiliations
- PMID: 19128206
- DOI: 10.2174/187152708787122969
Item in Clipboard
Review
Alzheimer's disease, ceramide, visfatin and NAD
CNS Neurol Disord Drug Targets.
2008 Dec.
Abstract
This review discusses new mechanisms for the induction of Alzheimer's disease, involving lipid toxicity and adipokines. Ceramide induces oxidative stress and the formation of amyloid beta. Visfatin induces oxidative stress, damages the blood brain barrier and increases the attraction of monocytes, neutrophils and other white blood cells. A new mechanism for visfatin/NAD (nicotinamide adenine dinucleotide)-induced oxidative stress is presented involving redox cycling catalyzed by xanthine dehydrogenase and NADH oxidase. These mechanisms are discussed in terms of the treatment of Alzheimer's disease.
Similar articles
-
Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer's disease.Neurotox Res. 2008 May-Jun;13(3-4):173-84. doi: 10.1007/BF03033501. Neurotox Res. 2008. PMID: 18522897 Review.
-
Membrane raft-lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin.Cardiovasc Res. 2011 Feb 1;89(2):401-9. doi: 10.1093/cvr/cvq286. Epub 2010 Sep 7. Cardiovasc Res. 2011. PMID: 20823276 Free PMC article.
-
Salidroside protects PC12 cells from Aβ1‑40‑induced cytotoxicity by regulating the nicotinamide phosphoribosyltransferase signaling pathway.Mol Med Rep. 2017 Sep;16(3):2700-2706. doi: 10.3892/mmr.2017.6931. Epub 2017 Jul 5. Mol Med Rep. 2017. PMID: 28714019 Free PMC article.
-
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2070-5. doi: 10.1073/pnas.0305799101. Epub 2004 Feb 15. Proc Natl Acad Sci U S A. 2004. PMID: 14970312 Free PMC article.
-
Impaired nicotinamide adenine dinucleotide (NAD+ ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment.J Diabetes Investig. 2020 Nov;11(6):1403-1419. doi: 10.1111/jdi.13303. Epub 2020 Jul 7. J Diabetes Investig. 2020. PMID: 32428995 Free PMC article. Review.
Cited by
-
Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner.Pflugers Arch. 2010 Mar;459(4):619-30. doi: 10.1007/s00424-009-0752-1. Epub 2009 Nov 8. Pflugers Arch. 2010. PMID: 19898975
-
Targeting Adipokines: A Promising Therapeutic Strategy for Epilepsy.Neurochem Res. 2024 Nov;49(11):2973-2987. doi: 10.1007/s11064-024-04219-4. Epub 2024 Jul 26. Neurochem Res. 2024. PMID: 39060767 Review.
-
Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines.Metab Brain Dis. 2014 Sep;29(3):563-8. doi: 10.1007/s11011-014-9501-z. Epub 2014 Feb 20. Metab Brain Dis. 2014. PMID: 24553879 Review.
-
Heteromeles Arbutifolia, a Traditional Treatment for Alzheimer's Disease, Phytochemistry and Safety.Medicines (Basel). 2016 Jul 7;3(3):17. doi: 10.3390/medicines3030017. Medicines (Basel). 2016. PMID: 28930127 Free PMC article.
-
Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.Curr Opin Investig Drugs. 2009 Oct;10(10):1049-60. Curr Opin Investig Drugs. 2009. PMID: 19777393 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical